KRISTEN MCCOY: Open Payments
NPI 1518417856 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 40 payments from 9 companies in 2025. Trend: 2023 $724 · 2024 $1,302 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $284 |
| Medtronic, Inc. | 1 | $149 |
| PFIZER INC. | 7 | $134 |
| AtriCure, Inc. | 1 | $117 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Lilly USA, LLC | 1 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
Products named: LEQVIO, AURORA EV-ICD MRI SURESCAN, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, ELIQUIS, ZEPBOUND, VYNDAQEL, VERQUVO, ENTRESTO.
Industry payments across MS — which companies pay providers there.
